Investors considering a purchase of Aegerion Pharmaceuticals Inc ... or a 11% annualized rate of return (at Stock Options Channel we call this the YieldBoost). Selling a put does not give an investor access to AEGR’s …
In Aegerion Pharmaceuticals, Inc. (NASDAQ:AEGR), Broadfin initiated a stake during the first quarter, initially …
Stake
Aegerion Pharmaceuticals, Inc. AEGR has been on a bit of a cold streak lately, but there might be light at the end of the tunnel for this overlooked stock. And for technical investors there is some hope when looking at AEGR
Aegerion Pharmaceuticals (AEGR): AEGR stock is up 3.7% today ... Article printed from InvestorPlace Media, http://investorplace.com/2014/10/hottest-healthcare-stocks-now-ptct-aegr-bkd-acad-ptct-aegr-bkd-2/.
Aegerion Pharmaceuticals, Inc. AEGR is expected to report first-quarter 2016 results on May 2. The company has an impressive track record, having beaten estimates in each of the last four trailing quarters with a positive …
Find out which companies are about to raise their dividend well before the news hits the Street with StreetInsider.com's Dividend Insider Elite. Sign-up for a FREE trial here. Aegerion Pharmaceuticals, Inc. …
Ning Yang, Ph.D. and Andrew McDonald, Ph.D. Aegerion's (AEGR) stock has risen roughly 50% since October 11, 2012. We attended the company's investor event in New York on October 23, and it's clear that investors …
Investors eyeing a purchase of Aegerion Pharmaceuticals Inc (Symbol: AEGR) stock, but cautious about paying the going market price of $23.29/share, might benefit from considering selling puts among the alternative …
Aegerion Pharmaceuticals, Inc. is expected to report first-quarter 2016 results on May 2. The company has an impressive track record, having beaten estimates in each of the last four trailing quarters with a positive …